Famotidine 20 MG Oral Tablet — RxCUI 310273
RxNorm drug concept · Semantic clinical drug
RxCUI 310273
Semantic clinical drug · SCD
● Current RxNorm concept 224 FDA products
699 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310273
Official nameFamotidine 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped224
Package NDCs mapped699
Reported Medicaid activity (SDUD)5,602,226 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Famotidine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It lowers stomach acid. It's used in the hospital for ulcers, GERD, or excess-acid conditions, especially when you can't take pills. It's typically used until you can switch to ora...
- Why am I getting famotidine through an IV?
- For adults it is generally given about every 12 hours through a vein. Your care team will set the exact dose and timing, which may be adjusted if your kidneys aren't working well.
- The common ones are headache, dizziness, constipation, and diarrhea. You may also notice brief irritation where the IV goes in. Tell your nurse about any of these.
🕸️ Concept Web — How Famotidine 20 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Famotidine 20 MG Oral Tablet
RxCUI 310273 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Famotidine
4278IN
-
Famotidine
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Calmicid
1091396BN -
Pepcid
196458BN -
Zantac Reformulated Aug 2022
2607010BN
-
Calmicid
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Famotidine Oral Tablet
372140SCDF -
Famotidine Oral Product
1159021SCDG -
Famotidine Pill
1159022SCDG -
Famotidine Oral Tablet [Calmicid]
1091398SBDF -
Famotidine Oral Tablet [Pepcid]
93732SBDF -
Famotidine Oral Tablet [Zantac Reformulated Aug 2022]
2607014SBDF -
Calmicid Oral Product
1172256SBDG -
Calmicid Pill
1172258SBDG - +7 more in this family
-
Famotidine Oral Tablet
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Famotidine 20 MG
315921SCDC -
Famotidine 20 MG Oral Tablet [Calmicid]
1091399SBD -
Famotidine 20 MG Oral Tablet [Pepcid]
104094SBD -
Famotidine 20 MG Oral Tablet [Zantac Reformulated Aug 2022]
2609246SBD -
Famotidine 20 MG [Calmicid]
1091397SBDC -
Famotidine 20 MG [Pepcid]
491217SBDC -
Famotidine 20 MG [Zantac Reformulated Aug 2022]
2609245SBDC
-
Famotidine 20 MG
Showing up to 8 concepts per family — 19 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Famotidine 20 MG
SCDC · 315921 -
Famotidine Oral Tablet
SCDF · 372140 -
Famotidine Oral Product
SCDG · 1159021 -
Famotidine Pill
SCDG · 1159022
Brand-Name Concepts
-
Famotidine 20 MG Oral Tablet [Calmicid]
SBD · 1091399 -
Famotidine 20 MG Oral Tablet [Pepcid]
SBD · 104094 -
Famotidine 20 MG Oral Tablet [Zantac Reformulated Aug 2022]
SBD · 2609246 -
Famotidine 20 MG [Calmicid]
SBDC · 1091397 -
Famotidine 20 MG [Pepcid]
SBDC · 491217 -
Famotidine 20 MG [Zantac Reformulated Aug 2022]
SBDC · 2609245 -
Famotidine Oral Tablet [Calmicid]
SBDF · 1091398 -
Famotidine Oral Tablet [Pepcid]
SBDF · 93732 -
Famotidine Oral Tablet [Zantac Reformulated Aug 2022]
SBDF · 2607014 -
Calmicid Oral Product
SBDG · 1172256
📦 FDA Products & Package NDCs
224 products · 699 package NDCs
699 package NDCs map to RxCUI 310273 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00113-0194-00 | 2 BOTTLE in 1 CARTON (0113-0194-00) / 200 TABLET, FILM COAT... | Good Sense Acid Reducer | L. Perrigo Company | 2024-10-31 |
| 00113-0194-02 | 25 BLISTER PACK in 1 CARTON (0113-0194-02) / 1 TABLET, FILM... | Good Sense Acid Reducer | L. Perrigo Company | 2007-03-16 |
| 00113-0194-71 | 1 BOTTLE in 1 CARTON (0113-0194-71) / 50 TABLET, FILM COATE... | Good Sense Acid Reducer | L. Perrigo Company | 2013-09-19 |
| 00113-0194-82 | 1 BOTTLE in 1 CARTON (0113-0194-82) / 200 TABLET, FILM COAT... | Good Sense Acid Reducer | L. Perrigo Company | 2024-05-30 |
| 00172-5728-60 | 100 TABLET, FILM COATED in 1 BOTTLE (0172-5728-60) | Famotidine | Teva Pharmaceuticals USA, Inc. | 2001-04-16 |
| 00172-5728-70 | 500 TABLET, FILM COATED in 1 BOTTLE (0172-5728-70) | Famotidine | Teva Pharmaceuticals USA, Inc. | 2001-04-16 |
| 00172-5728-80 | 1000 TABLET, FILM COATED in 1 BOTTLE (0172-5728-80) | Famotidine | Teva Pharmaceuticals USA, Inc. | 2001-04-16 |
| 00172-5729-60 | 100 TABLET, FILM COATED in 1 BOTTLE (0172-5729-60) | Famotidine | Teva Pharmaceuticals USA, Inc. | 2001-04-16 |
| 00172-5729-70 | 500 TABLET, FILM COATED in 1 BOTTLE (0172-5729-70) | Famotidine | Teva Pharmaceuticals USA, Inc. | 2001-04-16 |
| 00187-4420-10 | 100 TABLET, FILM COATED in 1 BOTTLE (0187-4420-10) | Pepcid | Bausch Health US LLC | 2001-04-16 |
| 00187-4420-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0187-4420-30) | Pepcid | Bausch Health US LLC | 2001-04-16 |
| 00187-4440-10 | 100 TABLET, FILM COATED in 1 BOTTLE (0187-4440-10) | Pepcid | Bausch Health US LLC | 2001-04-16 |
| 00187-4440-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0187-4440-30) | Pepcid | Bausch Health US LLC | 2001-04-16 |
| 00363-0701-82 | 1 BOTTLE in 1 CARTON (0363-0701-82) / 200 TABLET, FILM COAT... | Acid Controller | Walgreen Company | 2019-05-08 |
| 00363-0701-98 | 1 BOTTLE in 1 CARTON (0363-0701-98) / 75 TABLET, FILM COATE... | Acid Controller | Walgreen Company | 2026-03-13 |
| 00363-1203-71 | 1 BOTTLE in 1 CARTON (0363-1203-71) / 50 TABLET, FILM COATE... | acid controller | Walgreen Company | 2022-04-07 |
| 00363-1899-14 | 1 BOTTLE in 1 CARTON (0363-1899-14) / 50 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2022-02-18 |
| 00363-1899-24 | 1 BOTTLE in 1 CARTON (0363-1899-24) / 90 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2022-02-18 |
| 00363-1899-34 | 1 BOTTLE in 1 CARTON (0363-1899-34) / 200 TABLET, FILM COAT... | Famotidine | WALGREEN CO. | 2022-02-18 |
| 00363-1899-53 | 1 BOTTLE in 1 CARTON (0363-1899-53) / 25 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2022-02-18 |
| 00363-5300-14 | 1 BOTTLE in 1 CARTON (0363-5300-14) / 50 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2016-04-26 |
| 00363-5300-34 | 1 BOTTLE in 1 CARTON (0363-5300-34) / 200 TABLET, FILM COAT... | Famotidine | WALGREEN CO. | 2022-07-26 |
| 00363-5300-47 | 1 BOTTLE in 1 CARTON (0363-5300-47) / 75 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2024-02-17 |
| 00363-5300-50 | 1 BOTTLE in 1 CARTON (0363-5300-50) / 85 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2016-04-26 |
| 00363-5300-53 | 1 BOTTLE in 1 CARTON (0363-5300-53) / 25 TABLET, FILM COATE... | Famotidine | WALGREEN CO. | 2016-04-26 |
| 00536-1298-01 | 1 BOTTLE in 1 CARTON (0536-1298-01) / 100 TABLET, FILM COAT... | Rugby Famotidine | Rugby Laboratories | 2020-09-14 |
| 00615-8558-05 | 15 TABLET in 1 BLISTER PACK (0615-8558-05) | Famotidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2025-01-16 |
| 00615-8558-28 | 28 TABLET in 1 BLISTER PACK (0615-8558-28) | Famotidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2025-01-16 |
| 00615-8558-39 | 30 TABLET in 1 BLISTER PACK (0615-8558-39) | Famotidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2025-01-16 |
| 00615-8559-05 | 15 TABLET in 1 BLISTER PACK (0615-8559-05) | Famotidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2025-01-14 |
| 00615-8559-39 | 30 TABLET in 1 BLISTER PACK (0615-8559-39) | Famotidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2025-01-14 |
| 00904-5780-17 | 25 BLISTER PACK in 1 CARTON (0904-5780-17) / 1 TABLET, FILM... | Major Heartburn Relief Maximum Strength | Major Pharmaceuticals | 2006-10-04 |
| 00904-5780-51 | 1 BOTTLE in 1 CARTON (0904-5780-51) / 50 TABLET, FILM COATE... | Major Heartburn Relief Maximum Strength | Major Pharmaceuticals | 2006-09-29 |
| 00904-7193-06 | 50 BLISTER PACK in 1 CARTON (0904-7193-06) / 1 TABLET, FILM... | Famotidine | Major Pharmaceuticals | 2022-08-10 |
| 00904-7193-61 | 100 BLISTER PACK in 1 CARTON (0904-7193-61) / 1 TABLET, FIL... | Famotidine | Major Pharmaceuticals | 2001-04-16 |
| 10267-5689-01 | 100 TABLET, COATED in 1 BOTTLE (10267-5689-1) | Famotidine | Contract Pharmacal Corp. | 2024-08-31 |
| 10267-5689-04 | 1000 TABLET, COATED in 1 BOTTLE (10267-5689-4) | Famotidine | Contract Pharmacal Corp. | 2024-08-31 |
| 10267-5689-05 | 500 TABLET, COATED in 1 BOTTLE (10267-5689-5) | Famotidine | Contract Pharmacal Corp. | 2024-08-31 |
| 10267-5690-01 | 100 TABLET, COATED in 1 BOTTLE (10267-5690-1) | Famotidine | Contract Pharmacal Corp. | 2024-08-31 |
| 10267-5690-04 | 1000 TABLET, COATED in 1 BOTTLE (10267-5690-4) | Famotidine | Contract Pharmacal Corp. | 2024-08-31 |
| 10267-5690-05 | 500 TABLET, COATED in 1 BOTTLE (10267-5690-5) | Famotidine | Contract Pharmacal Corp. | 2024-08-31 |
| 11673-0697-01 | 2 BOTTLE in 1 CARTON (11673-697-01) / 50 TABLET in 1 BOTTLE | Maximum Strength Acid Reducer | TARGET CORPORATION | 2024-05-15 |
| 11673-0697-05 | 1 BOTTLE in 1 CARTON (11673-697-05) / 50 TABLET in 1 BOTTLE | Maximum Strength Acid Reducer | TARGET CORPORATION | 2024-05-15 |
| 11673-0697-20 | 1 BOTTLE in 1 CARTON (11673-697-20) / 200 TABLET in 1 BOTTL... | Maximum Strength Acid Reducer | TARGET CORPORATION | 2024-05-15 |
| 11673-0697-52 | 5 BLISTER PACK in 1 CARTON (11673-697-52) / 5 TABLET in 1 B... | Maximum Strength Acid Reducer | TARGET CORPORATION | 2024-05-15 |
| 11822-1014-00 | 1 BOTTLE in 1 CARTON (11822-1014-0) / 50 TABLET, FILM COATE... | acid relief | Rite Aid Corporation | 2022-03-31 |
| 11822-1194-01 | 1 BOTTLE in 1 CARTON (11822-1194-1) / 50 TABLET, FILM COATE... | acid relief | Rite Aid Corporation | 2023-03-15 |
| 11822-1194-02 | 25 BLISTER PACK in 1 CARTON (11822-1194-2) / 1 TABLET, FILM... | acid relief | Rite Aid Corporation | 2023-03-15 |
| 11822-1194-04 | 1 BOTTLE in 1 CARTON (11822-1194-4) / 100 TABLET, FILM COAT... | acid relief | Rite Aid Corporation | 2023-03-15 |
| 11822-1194-05 | 2 BOTTLE in 1 CARTON (11822-1194-5) / 100 TABLET, FILM COAT... | acid relief | Rite Aid Corporation | 2025-03-04 |
Observed labelers:
Bryant Ranch Prepack (77) ·
Proficient Rx LP (49) ·
Aurohealth LLC (25) ·
Preferred Pharmaceuticals Inc. (22) ·
A-S Medication Solutions (21) ·
Dr.Reddys Laboratories Limited (21)
· +110 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.